Susquehanna International Group, LLP Oragenics Inc Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.11 - $15.59 $16,164 - $2.29 Million	146,953 New	146,953 $16,000
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.42 $12,072 - $21,127	-50,303 Reduced 66.57%	25,260 $9,000
Q1 2022 May 16, 2022	BUY	$0.33 - $0.56 $1,703 - $2,890	5,161 Added 7.33%	75,563 $26,000
Q4 2021 Feb 14, 2022	BUY	$0.43 - $0.69 $30,272 - $48,577	70,402 New	70,402 $31,000
Q2 2020 Aug 14, 2020	SELL	$0.39 - $0.83 $14,994 - $31,911	-38,448 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.43 - $0.75 $6,093 - $10,629	14,172 Added 58.38%	38,448 $22,000
Q4 2019 Feb 14, 2020	BUY	$0.42 - $0.62 $10,195 - $15,051	24,276 New	24,276 $13,000
Q3 2019 Nov 14, 2019	SELL	$0.36 - $0.64 $6,689 - $11,892	-18,582 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.46 - $0.6 $8,547 - $11,149	18,582 New	18,582 $9,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.